Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Lund

Showing results (641-650 of 826) with videos related to

Pageof 83
Sort By:
European Journal of Heart Failure|March 6, 2026
Enhancing Heart Failure Care Through Registries: Lessons Learned from Nordic Countries' Implementation of GuidelinesPeder L Myhre, Felix Lindberg, Brian B Løgstrup, et al.
European Journal of Heart Failure|March 29, 2021
Identification of distinct phenotypic clusters in heart failure with preserved ejection fractionAlicia Uijl, Gianluigi Savarese, Ilonca Vaartjes, et al.
European Heart Journal|August 31, 2018
Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEFSanjiv J Shah, Carolyn S P Lam, Sara Svedlund, et al.
Diabetes Research and Clinical Practice|February 4, 2014
Glycaemic threshold for diabetes-specific retinopathy among individuals from Saudi Arabia, Algeria and PortugalT P Almdal, L N Handlos, M Valerius, et al.
Circulation Research|August 21, 2020
Hyperglycemia Induces Myocardial Dysfunction via Epigenetic Regulation of JunDShafaat Hussain, Abdul Waheed Khan, Alexander Akhmedov, et al.
Journal of Cardiac Failure|August 8, 2021
Empagliflozin in Heart Failure With Predicted Preserved Versus Reduced Ejection Fraction: Data From the EMPA-REG OUTCOME TrialGianluigi Savarese, Alicia Uijl, Lars H Lund, et al.
European Journal of Heart Failure|October 5, 2022
Association of epicardial adipose tissue with proteomics, coronary flow reserve, cardiac structure and function, and quality of life in heart failure with preserved ejection fraction: insights from the PROMIS-HFpEF studyAshwin Venkateshvaran, Ulrika Ljung Faxen, Camilla Hage, et al.
JACC. Heart Failure|October 4, 2025
Iron Deficiency Definitions in Heart Failure Across Ejection Fraction Phenotypes: Prevalence, Symptoms, and Cause-Specific OutcomesFelix Lindberg, Carin Corovic Cabrera, Lina Benson, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 10, 2018
Impact of body mass index on adverse events after implantation of left ventricular assist devices: An IMACS registry analysisStephen J Forest, Rongbing Xie, James K Kirklin, et al.
The Lancet. Haematology|December 22, 2015
Fiix-prothrombin time versus standard prothrombin time for monitoring of warfarin anticoagulation: a single centre, double-blind, randomised, non-inferiority trialPáll T Onundarson, Charles W Francis, Olafur S Indridason, et al.
Pageof 83

Showing results (641-650 of 826) with videos related to

Sort By:
Pageof 83
European Journal of Heart Failure|March 6, 2026
Enhancing Heart Failure Care Through Registries: Lessons Learned from Nordic Countries' Implementation of GuidelinesPeder L Myhre, Felix Lindberg, Brian B Løgstrup, et al.
European Journal of Heart Failure|March 29, 2021
Identification of distinct phenotypic clusters in heart failure with preserved ejection fractionAlicia Uijl, Gianluigi Savarese, Ilonca Vaartjes, et al.
European Heart Journal|August 31, 2018
Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEFSanjiv J Shah, Carolyn S P Lam, Sara Svedlund, et al.
Diabetes Research and Clinical Practice|February 4, 2014
Glycaemic threshold for diabetes-specific retinopathy among individuals from Saudi Arabia, Algeria and PortugalT P Almdal, L N Handlos, M Valerius, et al.
Circulation Research|August 21, 2020
Hyperglycemia Induces Myocardial Dysfunction via Epigenetic Regulation of JunDShafaat Hussain, Abdul Waheed Khan, Alexander Akhmedov, et al.
Journal of Cardiac Failure|August 8, 2021
Empagliflozin in Heart Failure With Predicted Preserved Versus Reduced Ejection Fraction: Data From the EMPA-REG OUTCOME TrialGianluigi Savarese, Alicia Uijl, Lars H Lund, et al.
European Journal of Heart Failure|October 5, 2022
Association of epicardial adipose tissue with proteomics, coronary flow reserve, cardiac structure and function, and quality of life in heart failure with preserved ejection fraction: insights from the PROMIS-HFpEF studyAshwin Venkateshvaran, Ulrika Ljung Faxen, Camilla Hage, et al.
JACC. Heart Failure|October 4, 2025
Iron Deficiency Definitions in Heart Failure Across Ejection Fraction Phenotypes: Prevalence, Symptoms, and Cause-Specific OutcomesFelix Lindberg, Carin Corovic Cabrera, Lina Benson, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 10, 2018
Impact of body mass index on adverse events after implantation of left ventricular assist devices: An IMACS registry analysisStephen J Forest, Rongbing Xie, James K Kirklin, et al.
The Lancet. Haematology|December 22, 2015
Fiix-prothrombin time versus standard prothrombin time for monitoring of warfarin anticoagulation: a single centre, double-blind, randomised, non-inferiority trialPáll T Onundarson, Charles W Francis, Olafur S Indridason, et al.
Pageof 83